PLUR

NASD Pluri Inc.
Oct 17, 2026 · 8:55 PM ET EOD Market Closed

$0.9299 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.9299, $0.0601 below the day’s high of $0.9900

YTD change
-68.90%
vs 20-day SMA
-7.87%
vs 200-day SMA
-62.62%

Price ranges

Previous day
$0.9299 $0.9900
open $0.9900 close $0.9299
-$0.0601 (-6.07%)
Today
$0.9299 $0.9900
$0.9299
Past week
$0.8500 $1.0000
from $1.0000 now $0.9299
-$0.0701 (-7.01%)
Past month
$0.8500 $1.1600
from $1.0800 now $0.9299
-$0.1501 (-13.90%)
This year
$0.8500 $3.9000
from $2.9900 now $0.9299
-$2.0601 (-68.90%)

Price & Performance

-2.69 (-74.31%) / 6M

$0.7147$1.75$2.80$3.84Apr 17Jul 20Oct 16

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 92.0% away from all-time highs of $11.5784
  • PLUR is down 69% since the beginning of the year
  • PLUR is down 79% over the past 12 months
  • PLUR is down 14% over the past 1 month
  • 0% of all PLUR investors are betting against PLUR

PLUR reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -78.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.5432
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $41.8M
Beta 1.44

Balance sheet & scale

IncomeN/A
Revenue$1.0M
Cash$7.8M
Debt$34.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $12.4M

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $790.74 -0.70%
IQV IQVIA Holdings Inc $266.90 -1.53%
CRL Charles River Laboratories International, Inc. $300.15 -1.99%
ICLR ICON Plc $170.18 -2.83%
IT Gartner, Inc. $205.35 -0.95%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.